ConductScience.org, home

Paper180200

Effect of human exogenous leukocyte interferon in cytomegalovirus infections.

Emödi G and 5 others. J Infect Dis, 1976. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Effect of human exogenous leukocyte interferon in cytomegalovirus infections. Papers, record 180200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/180200

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of human exogenous leukocyte interferon in cytomegalovirus infections.
PubMed
Journal
J Infect Dis
PubMed
Year
1976
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.65
iCite
Revised in PubMed
2019-05-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Emödi GG
2O'Reilly RR
3Müller AA
4Everson LKL K
5Binswanger UU
6Just MM

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytomegalovirus InfectionsMajor topic
InterferonsMajor topic
Adult
Cytomegalovirus
Female
Humans
Infant
Infant, Newborn
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lectins
Lymphocytes
Male
Virus Diseases

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
38063292Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors.J Gen Virol2023https://conductscience.org/library/papers/38063292PubMed
30449131Cyclophilin A as a target in the treatment of cytomegalovirus infections.Antivir Chem Chemother2018https://conductscience.org/library/papers/30449131PubMed
30403913Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines.Virulence2018https://conductscience.org/library/papers/30403913PubMed
29194430Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response.Viruses2017https://conductscience.org/library/papers/29194430PubMed
29021395
Human Cytomegalovirus Utilizes a Nontraditional Signal Transducer and Activator of Transcription 1 Activation Cascade via Signaling through Epidermal Growth Factor Receptor and Integrins To Efficiently Promote the Motility, Differentiation, and Polarization of Infected Monocytes.
J Virol2017https://conductscience.org/library/papers/29021395PubMed
25392213Abrogation of the interferon response promotes more efficient human cytomegalovirus replication.J Virol2015https://conductscience.org/library/papers/25392213PubMed
24013068The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.J Mol Biol2013https://conductscience.org/library/papers/24013068PubMed
6208021Interferons and viral infections.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6208021PubMed
6173188Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.Drugs1982https://conductscience.org/library/papers/6173188PubMed
6163727Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection.Infect Immun1981https://conductscience.org/library/papers/6163727PubMed
6163417Interferon therapy: pharmacokinetic and pharmacological aspects.Arch Virol1981https://conductscience.org/library/papers/6163417PubMed
6159043Interferon: therapeutic fact or fiction for the '80s?Br Med J1980https://conductscience.org/library/papers/6159043PubMed
500189Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans.Infect Immun1979https://conductscience.org/library/papers/500189PubMed
318786Cell-mediated immunity and its role in resistance to infection.West J Med1977https://conductscience.org/library/papers/318786PubMed
229129Herpesviruses.J Clin Pathol1979https://conductscience.org/library/papers/229129PubMed
206203Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/206203PubMed
193440Susceptibility of clinical isolates of cytomegalovirus to human interferon.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/193440PubMed
186979[Experiments with simultaneous immunization against cytomegalovirus infection and rubella].Soz Praventivmed1976https://conductscience.org/library/papers/186979PubMed
185951Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/185951PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/180200

GET https://conductscience.org/api/papers/v1/180200/authors